Clinical Trial Update: Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism [NA]

View source ↗

Summary

The document reports a clinical trial evaluating Acostream for high-risk and intermediate-risk acute pulmonary embolism, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Acostream

Snippet

Sponsor: RenJi Hospital | Conditions: Pulmonary Embolism (PE) | NA | Status: RECRUITING